Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A deep-dive into the economic modeling, cost-per-QALY estimates, payer-coverage implications, and individual patient value calculations derived from the ELITE trial of oral estradiol in early versus late menopause.
Read clinical reviewWhat the ELITE trial's follow-up and post-trial data reveal about durability of early-initiation HRT on carotid atherosclerosis, long-term safety, and cardiovascular outcomes beyond the original 5-year window.
Read clinical reviewA detailed examination of the ELITE trial's enrollment biases, statistical caveats, generalizability gaps, and what peer commentary revealed about this landmark early-HRT study.
Read clinical reviewHow the ELITE trial's timing hypothesis for estradiol and atherosclerosis should reshape HRT prescribing decisions, guideline updates, and patient selection today.
Read clinical review